Cargando…

Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies

The ability to tailor biologic therapy based on the status of tumor biomarkers and monoclonal antibodies has become very important in the last years. The role of tumor biomarkers in treating colorectal cancer, specifically the K-RAS gene, was identified. K-RAS had a higher interest after Lievre and...

Descripción completa

Detalles Bibliográficos
Autores principales: Popa, C, Ionescu, S, Mihăilă, D, Gal, I, Potecă, T, Simion, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391878/
https://www.ncbi.nlm.nih.gov/pubmed/22802884